Predict SpA LT Debt/Equity

What does Predict SpA do? Predict SpA generates revenue through the sale of medical diagnostic imaging systems such as ultrasound, x-ray, and magnetic resonance imaging equipment. The company also sells diagnostic technologies like Mistral, a breath analysis system for early gastrointestinal diagnosis, and products including Aphel, a humanoid robot for hospital assistance, and Optip, a holographic communication platform for remote collaboration. The firm targets healthcare providers and hospital systems within the local Italian market, focusing on non-invasive diagnostic solutions and advanced communication tools for medical environments. Predict SpA's revenue streams include direct sales of its medical equipment and diagnostic technologies to hospitals and healthcare facilities. The company's products are designed to improve diagnostic accuracy and patient care through innovative approaches, such as Mistral's breath analysis and Optip's holographic interaction capabilities. These offerings are tailored to meet the needs of healthcare professionals seeking efficient and modern solutions for patient management and diagnosis. The firm's business model revolves around developing and commercializing proprietary medical technologies that address specific healthcare challenges. By focusing on local operations in Bari, Italy, Predict SpA serves the domestic healthcare sector with products like Aphel and Optip, which support both patient assistance and remote communication in medical settings. Revenue is derived from the sale of these integrated systems to hospitals and healthcare providers seeking to enhance their diagnostic and communication capabilities. Predict SpA is one of the most popular companies on Eulerpool.